The SCRIPPS DES REAL WORLD Registry

CompletedOBSERVATIONAL
Enrollment

859

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Coronary Artery DiseaseCoronary RestenosisCoronary Thrombosis
Interventions
DEVICE

Sirolimus-Eluting Bx Velocity Coronary Stent (CypherTM Sirolimus-Eluting Stent)

Indications for use: The CYPHER™ Sirolimus-eluting Coronary Stent is indicated for improving coronary luminal diameter in patients with symptomatic ischemic disease due to discrete de novo lesions of length less than or equal to 30 mm in native coronary arteries with a reference vessel diameter between 2.5 and 3.5 mm. Long-term outcome (beyond 12 months) for this permanent implant is unknown at present.

Trial Locations (1)

92037

Scripps Green Hospital/Scripps Clinic Torrey Pines, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cordis Corporation

INDUSTRY

lead

Paul S Teirstein, MD

OTHER

NCT00714623 - The SCRIPPS DES REAL WORLD Registry | Biotech Hunter | Biotech Hunter